Internal Reference Number: FOI_7113
Date Request Received: 05/04/2023 00:00:00
Date Request Replied To: 18/04/2023 00:00:00
This response was sent via: By Email
Request Summary: Treatment of Haemophilia A
Request Category: Researcher
Question Number 1: How many haemophilia A patients are registered with your centre, and how many of these patients are classified as exhibiting mild, moderate, or severe disease. | |
Answer To Question 1: 17x Mild A <5 Moderate A <5 Severe A | |
Question Number 2: In the last three months, how many Haemophilia A patients, including on-demand patients, have been treated with the following products? • Advate • Adynovi • Elocta • Esperoct • Factor Eight Inhibitor Bypass Activity (FEIBA) • Hemlibra (standalone) • Hemlibra in combination with any Factor VIII • NovoEight • NovoSeven RT • Obizur • Refacto AF • Any other products | |
Answer To Question 2: ADVATE – <5 x Severe A Prophylactically, <5 x Mild A on demand ELOCTA – <5 x Severe A Prophylactically <5 x Severe A on demand <5 x Moderate Prophylactically HemLIBRA <5 x Severe A prophylactically | |
Question Number 3: For patients treated with Advate in the last three months, please provide: • the number of haemophilia A patients treated prophylactically • the number of haemophilia A patients treated for any other reason (e.g. surgery, on-demand, breakthrough bleeds) | |
Answer To Question 3: ADVATE <5 x Severe A <5 x Mild A <5 x Mild A treated a bleed | |
Question Number 4: In the last three months, how many patients were treated with the following products for severe Haemophila A ONLY? • Advate • Adynovi • Elocta • Esperoct • Factor Eight Inhibitor Bypass Activity (FEIBA) • Hemlibra (standalone) • Hemlibra in combination with any Factor VIII • NovoEight • NovoSeven RT • Obizur • Refacto AF • Any other products | |
Answer To Question 4: ADVATE <5 x Severe A ELOCTA <5 x Severe A HemLIBRA <5 x Severe A | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.